Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T33243 |
MC-Val-Cit-PAB-VX765
Belnacasan-conjugate,VX765-conjugate,MC-Val-Cit-PABC-VX765 |
||
MC-VAL-CIT-PAB-VX765 or MC-VAL-CIT-PABC-VX765 is a VX765 derivative that can be conjugated to antibodies, proteins, or polymers for targeted drug delivery. MC-Val- CIT -PAB is a cathepsin cleavable ADC connector, which has been widely used in the preparat | |||
T6090 |
Belnacasan
VX-765 |
Caspase | Apoptosis; Proteases/Proteasome |
Belnacasan (VX-765) 是一种具有口服活性的 IL 转换酶/caspase-1 抑制剂,是 VRT-043198 的口服生物活性前药,作用于外周血单核细胞,可抑制 LPS 诱导的 IL-1β 和 IL-18 释放。 |